Financial Gravity Companies’s AbbVie ABBV Stock Holding History

Financial Gravity Companies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.6K	Buy	+189	New	+$40.7K	0.01%	313
2025 Q2	$36.4K	Buy	+196	New	+$36.4K	0.01%	345
2024 Q4	$8.35K	Hold	47	–	–	﹤0.01%	602
2024 Q3	$9.28K	Buy	+47	New	+$8.77K	﹤0.01%	365
2018 Q4	$396K	Buy	+4,921	New	+$433K	0.36%	40
2018 Q1	$396K	Buy	3,949 +1,323	+50%	+$145K	0.41%	41
2017 Q4	$295K	Buy	+2,626	New	+$247K	0.34%	50

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Gravity Companies's ABBV Position: Q2 2026 in Review

Financial Gravity Companies opened a new position in AbbVie (ABBV) in Q2 2026: 189 shares worth $47.6K. The stake represents 0.01% of the portfolio and ranks #313 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in ABBV as recently as Q2 2025.

Financial Gravity Companies first reported a position in ABBV in Q4 2017 and has held it in 7 quarters since. The position peaked at $396K in Q4 2018. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Financial Gravity Companies held 189 shares of AbbVie worth $47.6K as of Q2 2026.
AbbVie was a new Financial Gravity Companies position in Q2 2026.
AbbVie made up 0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #313 holding.
Financial Gravity Companies first reported a position in AbbVie in Q4 2017 and has held it in 7 quarters since.
Financial Gravity Companies's AbbVie position peaked at $396K in Q4 2018.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.